
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2025 Earnings Call Transcript
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2025 Earnings Call Transcript May 6, 2025 Halozyme Therapeutics, Inc. beats earnings expectations. Reported EPS is $1.11, expectations were $0.95. Operator: Good afternoon. My name is Bailey, and I will be your …